Literature DB >> 3093811

Production and partial purification of human immune interferon.

K Cantell, S Hirvonen, H L Kauppinen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3093811     DOI： 10.1016/0076-6879(86)19009-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  6 in total

1.  Organoselenides as potential immunostimulants and inducers of interferon gamma and other cytokines in human peripheral blood leukocytes.

Authors:  A D Inglot; J Zielińska-Jenczylik; E Piasecki; L Syper; J Młochowski
Journal:  Experientia       Date:  1990-03-15

2.  Antiproliferative effects of natural interferon beta alone and in combination with natural interferon gamma on human breast carcinomas in nude mice.

Authors:  L Ozzello; D V Habif; C M DeRosa
Journal:  Breast Cancer Res Treat       Date:  1990-09       Impact factor: 4.872

3.  N-glycosylation of human interferon-gamma: glycans at Asn-25 are critical for protease resistance.

Authors:  T Sareneva; J Pirhonen; K Cantell; I Julkunen
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

4.  The use of natural interferon alpha conjugated to a monoclonal antibody anti mammary epithelial mucin (Mc5) for the treatment of human breast cancer xenografts.

Authors:  L Ozzello; C M De Rosa; E W Blank; K Cantell; R L Ceriani; D V Habif
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

5.  Role of N-glycosylation in the synthesis, dimerization and secretion of human interferon-gamma.

Authors:  T Sareneva; J Pirhonen; K Cantell; N Kalkkinen; I Julkunen
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

6.  Mitogenic activity of selenoorganic compounds in human peripheral blood leukocytes.

Authors:  J A Czyrski; A D Inglot
Journal:  Experientia       Date:  1991-01-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.